Recursion Pharmaceuticals, Inc.

MetLife Investment Management, LLC RXRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

209,801

Value ($000)

858

Weight

0.0%

2021 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	858	0.0%	209,801	12/31/2025
2025 Q3	11/13/2025	1,050	0.0%	215,240	9/30/2025
2025 Q2	8/13/2025	1,033	0.0%	204,080	6/30/2025
2025 Q1	5/14/2025	783	0.0%	148,007	3/31/2025
2024 Q4	2/13/2025	1,013	0.0%	149,808	12/31/2024
2024 Q3	11/13/2024	900	0.0%	136,541	9/30/2024
2024 Q2	8/13/2024	901	0.0%	120,136	6/30/2024
2024 Q1	5/14/2024	719	0.0%	72,161	3/31/2024
2023 Q4	4/22/2024	712	0.0%	72,161	12/31/2023
2023 Q3	5/9/2024	552	0.0%	72,161	9/30/2023
2023 Q2	4/29/2024	539	0.0%	72,161	6/30/2023
2023 Q1	5/9/2024	481	0.0%	72,161	3/31/2023
2022 Q4	5/10/2024	556	0.0%	72,161	12/31/2022
2022 Q3	5/10/2024	768	0.0%	72,161	9/30/2022
2022 Q2	5/10/2024	587	0.0%	72,161	6/30/2022
2022 Q1	5/10/2024	458	0.0%	64,035	3/31/2022
2021 Q4	5/17/2024	706	0.0%	41,202	12/31/2021
2021 Q3	5/17/2024	247	0.0%	10,751	9/30/2021
2021 Q2	5/17/2024	318	0.0%	8,708	6/30/2021